.png)
Antithrombin Market b ySourceand Application- Global Industry Analysis & Forecast to 2027
Published On : January 2021 Pages : 158 Category: Pharma & Healthcare Report Code : HC0115127
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Antithrombin Market By Source (Human, Goat Milk) and Application (Therapeutics, Research, Diagnostics, and Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Antithrombin Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Antithrombinis a glycoprotein produced by the liver that inactivates several enzymes of the coagulation system.Antithrombin activity is increased by anticoagulant heparin, which enhances the binding of antithrombin to factor II and factor X.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Antithrombin Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Grifols
- Shire Plc.
- CSL Limited
- KedrionS.p.A.
- Octapharma AG
- Lee Biosolutions
- Scripps Laboratories Inc.
- Kyowa Hakko Kirin Co. Ltd.,
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Antithrombin Market, BySource, Estimates and Forecast, 2017-2027 ($Million)
o Human
o Goat Milk
· Antithrombin Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Therapeutics
o Research
o Diagnostics
o Others
· Antithrombin Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Grifols
o Shire Plc.
o CSL Limited
o Kedrion S.p.A.
o Octapharma AG
o Lee Biosolutions
o Scripps Laboratories Inc.
o Kyowa Hakko Kirin Co. Ltd.,
· Antithrombin Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Antithrombin Market, By Country
o U.S. Antithrombin Market
o Canada Antithrombin Market
o Mexico Antithrombin Market
o Europe
§ Europe Antithrombin Market, By Country
o UK Antithrombin Market
o Germany Antithrombin Market
o France Antithrombin Market
o Russia Antithrombin Market
o Italy Antithrombin Market
o Rest of Europe Antithrombin Market
o Asia-Pacific
§ Asia-Pacific Antithrombin Market, By Country
o China Antithrombin Market
o Japan Antithrombin Market
o South Korea Antithrombin Market
o India Antithrombin Market
o Southeast Asia Antithrombin Market
o Rest of Asia-Pacific Antithrombin Market
o South America
§ South America Antithrombin Market
o Brazil Antithrombin Market
o Argentina Antithrombin Market
o Columbia Antithrombin Market
o Rest of South America Antithrombin Market
o Middle East and Africa
§ Middle East and Africa Antithrombin Market
o Saudi Arabia Antithrombin Market
o UAE Antithrombin Market
o Egypt Antithrombin Market
o Nigeria Antithrombin Market
o South Africa Antithrombin Market
o TurkeyAntithrombin Market
o Rest of MEA Antithrombin Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Antithrombin Market, By Source
5.1. Introduction
5.2. Global Antithrombin Revenue and Market Share by Source (2017-2021)
5.2.1. Global Antithrombin Revenue and Revenue Share by Source (2017-2021)
5.3. Human
5.3.1. Global Human Revenue and Growth Rate (2017-2021)
5.4. Goat Milk
5.4.1. Global Goat Milk Revenue and Growth Rate (2017-2021)
6. Antithrombin Market, By Applications
6.1. Introduction
6.2. Global Antithrombin Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Antithrombin Revenue and Revenue Share by Applications (2017-2021)
6.3. Therapeutics
6.3.1. Global Therapeutics Revenue and Growth Rate (2017-2021)
6.4. Research
6.4.1. Global Research Revenue and Growth Rate (2017-2021)
6.5. Diagnostics
6.5.1. Global Diagnostics Revenue and Growth Rate (2017-2021)
6.6. Others
6.6.1. Global Others Revenue and Growth Rate (2017-2021)
7. Antithrombin Market, By Region
7.1. Introduction
7.2. Global Antithrombin Revenue and Market Share by Regions
7.2.1. Global Antithrombin Revenue by Regions (2017-2021)
7.3. North America Antithrombin by Countries
7.3.1. North America Antithrombin Revenue and Growth Rate (2017-2021)
7.3.2. North America Antithrombin Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Antithrombin by Countries
7.4.1. Europe Antithrombin Revenue and Growth Rate (2017-2021)
7.4.2. Europe Antithrombin Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Antithrombin by Countries
7.5.1. Asia-Pacific Antithrombin Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Antithrombin Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Antithrombin by Countries
7.6.1. South America Antithrombin Revenue and Growth Rate (2017-2021)
7.6.2. South America Antithrombin Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Antithrombin by Countries
7.7.1. Middle East and Africa Antithrombin Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Antithrombin Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Antithrombin Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Grifols
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Shire Plc.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. CSL Limited
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Kedrion S.p.A.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Octapharma AG
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Lee Biosolutions
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Scripps Laboratories Inc.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Kyowa Hakko Kirin Co. Ltd.,
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
9. Antithrombin Market Forecast (2022-2027)
9.1. Global Antithrombin Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Antithrombin Market Forecast by Regions (2022-2027)
9.2.1. North America Antithrombin Market Forecast (2022-2027)
9.2.1.1. United States Antithrombin Market Forecast (2022-2027)
9.2.1.2. Canada Antithrombin Market Forecast (2022-2027)
9.2.1.3. Mexico Antithrombin Market Forecast (2022-2027)
9.2.2. Europe Antithrombin Market Forecast (2022-2027)
9.2.2.1. Germany Antithrombin Market Forecast (2022-2027)
9.2.2.2. France Antithrombin Market Forecast (2022-2027)
9.2.2.3. UK Antithrombin Market Forecast (2022-2027)
9.2.2.4. Russia Antithrombin Market Forecast (2022-2027)
9.2.2.5. Italy Antithrombin Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Antithrombin Market Forecast (2022-2027)
9.2.3. Asia-Pacific Antithrombin Market Forecast (2022-2027)
9.2.3.1. China Antithrombin Market Forecast (2022-2027)
9.2.3.2. Japan Antithrombin Market Forecast (2022-2027)
9.2.3.3. Korea Antithrombin Market Forecast (2022-2027)
9.2.3.4. India Antithrombin Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Antithrombin Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Antithrombin Market Forecast (2022-2027)
9.2.4. South America Antithrombin Market Forecast (2022-2027)
9.2.4.1. Brazil Antithrombin Market Forecast (2022-2027)
9.2.4.2. Argentina Antithrombin Market Forecast (2022-2027)
9.2.4.3. Columbia Antithrombin Market Forecast (2022-2027)
9.2.4.4. Rest of South America Antithrombin Market Forecast (2022-2027)
9.2.5. Middle East and Africa Antithrombin Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Antithrombin Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Antithrombin Market Forecast (2022-2027)
9.2.5.3. Egypt Antithrombin Market Forecast (2022-2027)
9.2.5.4. Nigeria Antithrombin Market Forecast (2022-2027)
9.2.5.5. South Africa Antithrombin Market Forecast (2022-2027)
9.2.5.6. Turkey Antithrombin Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Antithrombin Market Forecast (2022-2027)
9.3. Antithrombin Market Forecast by Source (2022-2027)
9.3.1. Antithrombin Forecast by Source (2022-2027)
9.3.2. Antithrombin Market Share Forecast by Source (2022-2027)
9.4. Antithrombin Market Forecast by Applications (2022-2027)
9.4.1. Antithrombin Forecast by Applications (2022-2027)
9.4.2. Antithrombin Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Antithrombin Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Antithrombin Revenue and Revenue Share by Source (2017-2019)
Figure Global Human Revenue and Growth Rate (2017-2019)
Figure Global Goat Milk Revenue and Growth Rate (2017-2019)
Table Global Antithrombin Revenue and Revenue Share by Applications (2017-2019)
Figure Global Therapeutics Revenue and Growth Rate (2017-2019)
Figure Global Research Revenue and Growth Rate (2017-2019)
Figure Global Diagnostics Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Antithrombin Revenue by Regions (2017-2019)
Figure North America Antithrombin Growth Rate (2017-2019)
Figure North America Antithrombin Revenue and Growth Rate (2017-2019)
Figure North America Antithrombin by Countries (2017-2019)
Figure North America Antithrombin Revenue (Million USD) by Countries (2017-2019)
Figure United States Antithrombin Growth Rate (2017-2019)
Figure United States Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Antithrombin Growth Rate (2017-2019)
Figure Canada Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Antithrombin Growth Rate (2017-2019)
Figure Mexico Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Antithrombin Growth Rate (2017-2019)
Figure Europe Antithrombin Revenue and Growth Rate (2017-2019)
Figure Europe Antithrombin by Countries (2017-2019)
Figure Europe Antithrombin Revenue (Million USD) by Countries (2017-2019)
Figure Germany Antithrombin Growth Rate (2017-2019)
Figure Germany Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Antithrombin Growth Rate (2017-2019)
Figure France Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Antithrombin Growth Rate (2017-2019)
Figure UK Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Antithrombin Growth Rate (2017-2019)
Figure Russia Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Antithrombin Growth Rate (2017-2019)
Figure Italy Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Antithrombin Growth Rate (2017-2019)
Figure Rest of Europe Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Antithrombin Growth Rate (2017-2019)
Figure Asia-Pacific Antithrombin Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Antithrombin by Countries (2017-2019)
Figure Asia-Pacific Antithrombin Revenue (Million USD) by Countries (2017-2019)
Figure China Antithrombin Growth Rate (2017-2019)
Figure China Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Antithrombin Growth Rate (2017-2019)
Figure Japan Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Antithrombin Growth Rate (2017-2019)
Figure Korea Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Antithrombin Growth Rate (2017-2019)
Figure India Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Antithrombin Growth Rate (2017-2019)
Figure Southeast Asia Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Antithrombin Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Antithrombin Growth Rate (2017-2019)
Figure South America Antithrombin Revenue and Growth Rate (2017-2019)
Figure South America Antithrombin by Countries (2017-2019)
Figure South America Antithrombin Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Antithrombin Growth Rate (2017-2019)
Figure Brazil Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Antithrombin Growth Rate (2017-2019)
Figure Argentina Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Antithrombin Growth Rate (2017-2019)
Figure Columbia Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Antithrombin Growth Rate (2017-2019)
Figure Rest of South America Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Antithrombin Growth Rate (2017-2019)
Figure Middle East and Africa Antithrombin Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Antithrombin by Countries (2017-2019)
Figure Middle East and Africa Antithrombin Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Antithrombin Growth Rate (2017-2019)
Figure Saudi Arabia Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Antithrombin Growth Rate (2017-2019)
Figure United Arab Emirates Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Antithrombin Growth Rate (2017-2019)
Figure Egypt Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Antithrombin Growth Rate (2017-2019)
Figure Nigeria Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Antithrombin Growth Rate (2017-2019)
Figure South Africa Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Antithrombin Growth Rate (2017-2019)
Figure Turkey Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Antithrombin Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Antithrombin Revenue (Millions USD) and Growth Rate (2017-2019)
Table Grifols Antithrombin Financial Overview
Table Shire Plc. Antithrombin Financial Overview
Table CSL Limited Antithrombin Financial Overview
Table Kedrion S.p.A. Antithrombin Financial Overview
Table Octapharma AG Antithrombin Financial Overview
Table Lee Biosolutions Antithrombin Financial Overview
Table Scripps Laboratories Inc. Antithrombin Financial Overview
Table Kyowa Hakko Kirin Co. Ltd., Antithrombin Financial Overview
Figure Global Antithrombin Revenue (Millions USD) and Growth Rate (2019-2027)
Table Antithrombin Market Forecast by Regions (2019-2027)
Figure North America Antithrombin Market Forecast (2019-2027)
Figure United States Antithrombin Market Forecast (2019-2027)
Figure Canada Antithrombin Market Forecast (2019-2027)
Figure Mexico Antithrombin Market Forecast (2019-2027)
Figure Europe Antithrombin Market Forecast (2019-2027)
Figure Germany Antithrombin Market Forecast (2019-2027)
Figure France Antithrombin Market Forecast (2019-2027)
Figure UK Antithrombin Market Forecast (2019-2027)
Figure Russia Antithrombin Market Forecast (2019-2027)
Figure Italy Antithrombin Market Forecast (2019-2027)
Figure Rest of Europe Antithrombin Market Forecast (2019-2027)
Figure Asia-Pacific Antithrombin Market Forecast (2019-2027)
Figure China Antithrombin Market Forecast (2019-2027)
Figure Japan Antithrombin Market Forecast (2019-2027)
Figure Korea Antithrombin Market Forecast (2019-2027)
Figure India Antithrombin Market Forecast (2019-2027)
Figure Southeast Asia Antithrombin Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Antithrombin Market Forecast (2019-2027)
Figure South America Antithrombin Market Forecast (2019-2027)
Figure Brazil Antithrombin Market Forecast (2019-2027)
Figure Argentina Antithrombin Market Forecast (2019-2027)
Figure Columbia Antithrombin Market Forecast (2019-2027)
Figure Rest of South America Antithrombin Market Forecast (2019-2027)
Figure Middle East and Africa Antithrombin Market Forecast (2019-2027)
Figure Saudi Arabia Antithrombin Market Forecast (2019-2027)
Figure United Arab Emirates Antithrombin Market Forecast (2019-2027)
Figure Egypt Antithrombin Market Forecast (2019-2027)
Figure Nigeria Antithrombin Market Forecast (2019-2027)
Figure South Africa Antithrombin Market Forecast (2019-2027)
Figure Turkey Antithrombin Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Antithrombin Market Forecast (2019-2027)
Figure Global Antithrombin Forecast by Source (2019-2027)
Figure Global Antithrombin Market Share Forecast by Source (2019-2027)
Figure Global Antithrombin Forecast by Source (2019-2027)
Figure Global Antithrombin Forecast by Applications (2019-2027)
Figure Global Antithrombin Market Share Forecast by Applications (2019-2027)
Figure Global Antithrombin Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|